News

COVID-19 significantly delayed melanoma diagnoses and treatments, leading to increased disease severity and advanced cases, highlighting urgent health care needs.

Arcutis Biotherapeutics seeks FDA approval for Zoryve cream to treat plaque psoriasis in children as young as 2, addressing a critical treatment gap.

While survival rates were similar across income levels, lower-income patients consistently presented with more aggressive disease.

Research shows it can take 7 to 10 years for individuals with HS to receive an accurate diagnosis.

Explore the latest insights on skin and scalp care, focusing on cultural sensitivity and early intervention for diverse dermatological needs.

Allergan Aesthetics has launched an initiative to educate on HA fillers, emphasizing safety and natural results, backed by expert insights and patient satisfaction data.

Discover how 529 plans empower dermatologists to save for college, offering tax benefits and new Roth IRA transfer options for added flexibility.

Happy Head's StrandIQ system revolutionizes hair loss treatment with personalized genetic analysis, enhancing hair growth and scalp health for individuals.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Vimal Prajapati, MD, FRCPC, DABD, reviews the mechanism of action, clinical trial outcomes, monitoring considerations, and safety profile of recently available deuruxolitinib.

Sofia Wenzler, PhD, addresses misconceptions about dermatillomania (skin picking) and trichotillomania (hair pulling), advocating for compassionate care and accessible treatment for BFRBs.

Explore effective strategies for managing CSU, including tailored therapies and the latest treatment advancements for optimal patient care.

Almirall and Absci enhance their collaboration, leveraging AI to revolutionize drug discovery for challenging dermatological conditions and improve patient outcomes.

The FDA cited concerns about patient population heterogeneity and confirmatory trial design.

Experts in Miami Beach emphasized that adherence often drives biologic choice more than efficacy in real-world psoriasis care.

Biofrontera Inc. advances acne treatment with aminolevulinic acid hydrochloride gel, completing a phase 2b study for moderate to severe cases.

Dermatology Times has compiled a list of dermatological meetings taking place during the month of September.

Cases of dermatitis in workers and consumers alike show how allergen exposure transcends occupational boundaries.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.

In case you missed it, this week we had news about the potential of an mRNA vaccine for acne, the clinical role of DecisionDx-SCC, the presence of global dermatology deserts, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Test your knowledge of key words and terms associated with dermatology news from the last month.

Nemvaleukin alfa produced a disease control rate of 50% in advanced melanoma and RCC.

Explore the latest breakthroughs in treatment and research during Hair Loss Awareness Month, enhancing understanding and patient care for hair loss disorders.

Katrina Lee, MD, discussed innovative strategies and challenges in managing HS at the Dermatology Innovation Symposium, emphasizing early intervention and comprehensive care.

Discover how bond-building hair care treatments enhance hair strength and resilience, utilizing innovative technologies for healthier, more vibrant locks.

Catch up on dermatology news, highlights, and insights from the past 24 hours.